Nexalin Technology (NXL) Cost of Revenue (2021 - 2026)
Nexalin Technology's quarterly Cost of Revenue came in at $1817.0 in Q1 2026, down 86.6% year-on-year from $13558.0 in Q1 2025, and down 91.36% quarter-over-quarter from $21029.0 in Q4 2025.
Nexalin Technology has reported Cost of Revenue for 6 years, with the latest figure at $1817.0 in Q1 2026.
- For the quarter ending Q1 2026, Cost of Revenue fell 86.6% year-over-year to $1817.0; the trailing twelve-month figure through Mar 2026 stood at $49632.0 (up 21.07% YoY), and the FY2025 full-year result was $61373.0, up 67.72% from the prior year.
- Cost of Revenue for Q1 2026 stood at $1817.0, down from $21029.0 in the prior quarter.
- The five-year high for Cost of Revenue was $187298.0 in Q3 2022, with the low at $1817.0 in Q1 2026.
- Average Cost of Revenue over 5 years is $28746.1, with a median of $9156.0 recorded in 2024.
- Year-over-year, Cost of Revenue soared 1912.66% in 2022 and slumped 97.88% in 2023.
- Tracing NXL's Cost of Revenue over 5 years: stood at $6867.0 in 2022, then decreased by 23.82% to $5231.0 in 2023, then jumped by 43.3% to $7496.0 in 2024, then jumped by 180.54% to $21029.0 in 2025, then tumbled by 91.36% to $1817.0 in 2026.
- The last three Cost of Revenue figures came in at $1817.0 (Q1 2026), $21029.0 (Q4 2025), and $3948.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.26 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.51 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 441.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 481.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 891.20 Mn |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 | 1,817.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,817.00 |
| Mar 31, 2026 | 1,817.00 |
| Dec 31, 2025 | 21,029.00 |
| Dec 31, 2025 | 21,029.00 |
| Sep 30, 2025 | 3,948.00 |
| Sep 30, 2025 | 3,948.00 |
| Jun 30, 2025 | 22,838.00 |
| Jun 30, 2025 | 22,838.00 |
| Mar 31, 2025 | 13,558.00 |
| Mar 31, 2025 | 13,558.00 |
| Dec 31, 2024 | 7,496.00 |
| Dec 31, 2024 | 7,496.00 |
| Sep 30, 2024 | 12,694.00 |
| Sep 30, 2024 | 12,694.00 |
| Jun 30, 2024 | 7,247.00 |
| Jun 30, 2024 | 7,247.00 |
| Mar 31, 2024 | 9,156.00 |
| Mar 31, 2024 | 9,156.00 |
| Dec 31, 2023 | 5,231.00 |
| Dec 31, 2023 | 5,231.00 |
| Sep 30, 2023 | 3,973.00 |
| Sep 30, 2023 | 3,973.00 |
| Jun 30, 2023 | 9,374.00 |
| Jun 30, 2023 | 9,374.00 |
| Mar 31, 2023 | 7,110.00 |
| Mar 31, 2023 | 7,110.00 |
| Dec 31, 2022 | 6,867.00 |
| Dec 31, 2022 | 6,867.00 |
| Sep 30, 2022 | 187,298.00 |
| Sep 30, 2022 | 187,298.00 |
| Jun 30, 2022 | 123,032.00 |
| Jun 30, 2022 | 123,032.00 |
| Mar 31, 2022 | 46,015.00 |
| Mar 31, 2022 | 46,015.00 |
| Dec 31, 2021 | -1,006.00 |
| Dec 31, 2021 | -1,006.00 |
| Sep 30, 2021 | 9,306.00 |
| Sep 30, 2021 | 9,306.00 |